The great promise of digital health is unleashing value: we can improve outcomes and avoid costs by resolving hassles for patients and physicians, driving more efficient use of resources, and ultimately reducing costly care episodes.
MARLBOROUGH, Mass., Oct. 1, 2018– Boston Scientific Corporation (NYSE: BSX) today announced a worldwide call for submissions to the fourth annual Boston Scientific Connected Patient Challenge, an open competition to promote the development of meaningful innovation to address complex healthcare challenges. This year’s competition, co-sponsored by Google Cloud, will focus on applying patient or population health data, patient monitoring, and/or predictive analytics to improve care for patients with chronic conditions.
“The great promise of digital health is unleashing value: we can improve outcomes and avoid costs by resolving hassles for patients and physicians, driving more efficient use of resources, and ultimately reducing costly care episodes,” said David Feygin, vice president, Information Technology and Chief Digital Health Officer, Boston Scientific. “The Connected Patient Challenge empowers more meaningful conversations about these issues, strengthening our innovation ecosystem and ultimately creating opportunities to improve patient care.”
The competition will be hosted on Medstro, an interactive social media platform for physicians, where entrants will receive feedback on their concepts from expert panelists and the general community. Finalists will be chosen by popular vote on the site as well as by a panel of expert judges.
Interested parties can apply on the Connected Patient Challenge website until January 4, 2019. Winners will be chosen at a live pitch-off event at the Google office in Cambridge, MA, on February 27, 2019 where contestents will present their ideas to a panel of expert judges. The winners will receive up to $50,000 in in-kind support from Boston Scientific and Google.
Last year’s competition focused on the role of the Internet of Things in influencing patient outcomes. The winner, XcellCure, a startup biotechnology company, developed the AmIAware cardiac microarray concept to detect early warning signs of a heart attack in patients with chest pain. The award enabled the company used to further develop this platform and they are working with the Boston Scientific Interventional Cardiology team to refine the value proposition based on a double blind study collecting physician feedback.
*Note: Employees of Boston Scientific Corporation, the principal sponsor, will not be eligible to submit ideas. However, they will not be excluded from commenting on or adding to ideas submitted by other participants.
About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.
